Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Incyte	At The Market	Private Placement	Follow On Offering	Follow On Offering Common Stock and Warrants	Follow On Offering Preferred Stock and Warrants	Common Stock	Common Stock Incyte	Common Stock At The Market	Common Stock Private Placement	Common Stock Follow On Offering	Common Stock Follow On Offering Common Stock and Warrants	Series A Convertible Preferred Stock	Series A Convertible Preferred Stock Follow On Offering Preferred Stock and Warrants	Additional Paid-In Capital	Additional Paid-In Capital Incyte	Additional Paid-In Capital At The Market	Additional Paid-In Capital Private Placement	Additional Paid-In Capital Follow On Offering	Additional Paid-In Capital Follow On Offering Common Stock and Warrants	Additional Paid-In Capital Follow On Offering Preferred Stock and Warrants	Accumulated Other Comprehensive (Loss) Gain	Accumulated Deficit
Balance at Dec. 31, 2016	$ 80,602							$ 23								$ 181,844							$ (9)	$ (101,256)
Balance (in shares) at Dec. 31, 2016								23,380,888
Exercise of stock options and vesting of restricted stock awards	1,799															1,799
Exercise of stock options and vesting of restricted stock awards (in shares)								449,896
Issuance of common stock, net of issuance costs				$ 32,547							$ 3								$ 32,544
Issuance of common stock, net of costs and fees (in shares)											2,592,591
Stock-based compensation expense	4,419															4,419
Other comprehensive gain (loss)	(33)																						(33)
Net loss	(54,010)																							(54,010)
Balance at Dec. 31, 2017	65,324							$ 26								220,606							(42)	(155,266)
Balance (in shares) at Dec. 31, 2017								26,423,375
Exercise of stock options	626															626
Exercise of stock options, Shares								214,533
Issuance of common stock, net of issuance costs		$ 7,648	$ 16,538	$ 1,380	$ 42,700				$ 1	$ 1		$ 6					$ 7,647	$ 16,537	$ 1,380	$ 42,694
Issuance of common stock, net of costs and fees (in shares)									793,021	1,373,677	144,505	4,816,753
Stock-based compensation expense	6,610															6,610
Other comprehensive gain (loss)	39																						39
Net loss	(62,279)																							(62,279)
Balance at Dec. 31, 2018	$ 78,586							$ 34								296,100							(3)	(217,545)
Balance (in shares) at Dec. 31, 2018	33,765,864							33,765,864
Balance (in shares) at Dec. 31, 2018	0
Exercise of stock options	$ 211															211
Exercise of stock options, Shares	60,181							60,181
Issuance of common stock, net of issuance costs			$ 799			$ 60,359	$ 4,638						$ 9					$ 799			$ 60,350	$ 4,638
Issuance of common stock, net of costs and fees (in shares)										180,787			8,667,333		666
Conversion of preferred stock, Shares								666,000						(666)
Issuance of shares under Employee Stock Purchase Plan	$ 161															161
Issuance of shares under Employee Stock Purchase Plan, Shares								27,386
Exercise of warrants	2															2
Exercise of warrants, Shares								250
Stock-based compensation expense	9,839															9,839
Other comprehensive gain (loss)	27																						27
Net loss	(75,438)																							(75,438)
Balance at Dec. 31, 2019	$ 79,184							$ 43								$ 372,100							$ 24	$ (292,983)
Balance (in shares) at Dec. 31, 2019	43,367,801							43,367,801
Balance (in shares) at Dec. 31, 2019	0